COMP <GO>
ENS vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
EnerSys (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ENS 9
— TMO 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ENS
LAST: $159.95 (-6.66%) • MKT CAP: $6.18B
roic
13.00%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.40% | 41.00% | +22.40 | ENS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 13.00% | 9.30% | +3.70 | ENS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.9x | 30.4x | -16.50 | ENS | /valuation <GO> |
| Free Cash Flow Yield | 7.56% | 2.40% | +5.16 | ENS | /fcf-yield <GO> |
| Operating Margin | 24.60% | 17.40% | +7.20 | ENS | /operating-margins <GO> |
| Net Profit Margin | 17.00% | 15.10% | +1.90 | ENS | /net-margins <GO> |
| Revenue Growth (YoY) | -3.30% | 3.90% | -7.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.62% | 0.24% | +0.38 | ENS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.83 | 4.50 | -0.67 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.70% | +0.40 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.3 | 59.1 | -24.85 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.94 | +0.12 | ENS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.5x | 36.3x | -16.80 | ENS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.18B | $262.22B | -$256.04B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENS REV | TMO REV | ENS GROSS % | TMO GROSS % | ENS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $44.56B | — | 44.0% | $467.5M | $6.29B |
| FY 2024 | $0 | $42.88B | — | 44.0% | $139.3M | $7.27B |
| FY 2023 | $0 | $42.86B | — | 44.0% | $457.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENS // BETA 1.06
TMO // BETA 0.94